查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1886012

全球心臟帮浦市场

Heart Pump Devices
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2030年，全球心臟辅助设备市场规模将达85亿美元。

全球心臟辅助设备市场规模在2024年估计为32亿美元，预计到2030年将达到85亿美元，在分析期（2024-2030年）内复合年增长率（CAGR）为17.4%。本报告分析的细分市场之一－心室辅助设备（VAD）预计将以19.1%的复合年增长率成长，并在分析期结束时达到51亿美元。主动脉内球囊反搏帮浦（IABP）细分市场预计在分析期间内将以14.6%的复合年增长率成长。

美国市场规模估计为8.846亿美元，而中国市场预计将以16.4%的复合年增长率成长。

预计到2024年，美国心臟帮浦设备市场规模将达到8.846亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到13亿美元，在2024年至2030年的分析期间内，复合年增长率（CAGR）将达到16.4%。其他值得关注的区域市场包括日本和加拿大，预计在分析期内，这两个市场的复合年增长率将分别达到15.7%和14.2%。在欧洲，德国的复合年增长率预计将达到约11.2%。

全球心臟帮浦设备市场－主要市场趋势与驱动因素概述

为什么心臟帮浦在治疗晚期心臟衰竭、辅助心血管手术和提高患者存活率方面变得越来越重要？

心臟帮浦对于治疗晚期心臟衰竭、辅助心血管手术以及提高患者存活率至关重要。那么，为什么这些装置在今天如此重要？随着全球心臟衰竭盛行率的不断上升，心臟泵，例如左心室辅助装置（LVAD）和经关节人工心臟（TAH），为那些对药物或常规治疗方法不再有效的患者提供了挽救生命的解决方案。这些装置对于支持或完全替代衰竭的心臟至关重要，它们可以帮助心臟更有效地泵血，并确保重要器官持续获得充足的氧气和营养。对于许多末期心臟衰竭患者而言，心臟帮浦是他们在等待心臟移植期间维持生命的唯一现实选择，或在无法进行心臟移植时作为长期替代方案。

除了用于治疗心臟衰竭外，心臟帮浦在支持接受高风险心血管手术的患者方面也发挥着至关重要的作用。在这些手术过程中，心臟帮浦提供的临时机械循环支援可以维持血液流动，并降低术中和术后併发症的风险。此外，当心臟本身无法泵出足够的血液时，这些装置也越来越多地用于稳定从心肌梗塞或心源性休克中恢復的严重患者。

此外，心臟泵血装置能够显着改善心臟衰竭患者的生活品质，减轻疲劳、呼吸困难和体液储存等症状。透过辅助心臟功能，患者可以更轻鬆地进行日常活动，从而改善身心健康。

科技进步与创新如何让心臟辅助设备更有效率、更安全、更耐用？

技术进步和创新显着提高了心臟泵血装置的效率、安全性和耐用性，使其成为治疗方法心臟衰竭患者更可靠、更有效的方案。其中一项最具影响力的创新是开发出更小巧、更耐用、创伤更小的左心室辅助装置（LVAD）。这些新一代LVAD旨在降低植入手术风险，并改善患者预后。小型化技术的创新使其适用于更广泛的患者群体，包括那些因体型原因而仿单标示外使用旧型号装置的患者。此外，小型化也减少了大规模的必要性，从而降低了感染疾病和血栓等併发症。

心臟帮浦技术的另一个重要进展是能源效率和电池寿命的提升。早期的心臟帮浦设备需要患者随身携带外接电池，这限制了患者的活动能力和便利性。如今，先进的电池技术提供了持久耐用的便携式电源，减少了频繁更换和充电的需求。一些设备也正在探索无线充电技术，这将彻底消除对外部电源线的依赖，进一步提升患者的生活品质。这些改进使心臟泵设备更加实用、创伤更小，让患者能够拥有更自由和独立的生活。

人工智慧 (AI) 与数据分析的整合是心臟泵设备的另一项关键创新。 AI 驱动的监测系统持续追踪设备效能和病患生理参数，以便及早发现潜在问题，并在出现故障或劣化征兆时向医护人员发出警报。这些智慧系统有助于优化设备设置，进行即时调整，确保心臟泵以最佳效率运作。 AI 演算法甚至可以预测患者何时需要医疗干预，从而改善长期疗效并降低併发症风险。

生物相容性材料是心臟泵装置领域另一个取得显着进展的面向。这些装置中使用的新型材料降低了血栓症和感染的风险，而血栓和感染是心臟泵常见的併发症。使用先进的涂层和模拟生物组织的材料可以最大限度地减少免疫系统对装置的反应，从而减少对抗凝血剂和其他药物的需求。这不仅提高了患者的安全性，而且透过减少磨损延长了装置的使用寿命。

远端监测功能正在改变心臟帮浦设备的管理方式。如今，透过互联的医疗平台，可以对植入心臟帮浦的患者进行远端监测，使医护人员能够即时追踪设备性能和患者健康指标。这有助于及早发现潜在问题，减少患者频繁就医的次数，同时也让患者和医护人员都感到安心。此外，远端监测技术的进步意味着患者不再需要频繁住院，并且更有可能获得个人化护理和治疗方案的调整。

为什么心臟辅助装置对降低心臟衰竭患者的再入院率、延长平均寿命和提高生活品质如此重要？

由于心臟泵装置为患有严重心臟疾病的患者提供了长期解决方案，因此对于降低再入院率、延长平均寿命和提高心臟衰竭患者的生活品质至关重要。心臟帮浦装置如此宝贵的原因之一是其能够减少慢性心臟衰竭患者的再入院次数。心臟衰竭的特征通常是症状反覆出现，随着心臟泵血能力的下降，会导致患者反覆住院。心臟辅助装置透过持续支持心臟功能、稳定患者病情并减少频繁医疗干预的需求来缓解这一问题。这不仅提高了患者的生活质量，而且透过减少对急诊和医院资源的需求，减轻了医疗保健系统的压力。

心臟辅助装置的另一个主要益处是平均寿命。若不进行先进治疗方法，末期心臟衰竭患者的预期平均寿命通常只有几个月到几年。心臟辅助装置，特别是左心室辅助装置（LVAD），能够支持等待心臟移植患者的心臟功能，并且已被证明在移植不可行的情况下，作为长期治疗手段，能够显着延长患者的生存期。在许多情况下，植入LVAD的患者可以依靠该装置存活数年，从而有时间接受其他治疗并维持更高的生活品质。

改善心臟衰竭患者的生活品质是心臟辅助装置的关键好处之一。心臟衰竭会严重限制患者的日常生活能力，导致疲劳、呼吸困难和参与体育活动的能力下降。心臟帮浦装置透过改善血液循环来缓解这些症状，使患者恢復体力和精力。这有助于他们拥有更积极的生活方式、参与社交活动，并增强独立感。许多接受心臟帮浦装置植入的患者表示，植入后的身心健康状况都显着改善了。

心臟帮浦也为不适合心臟移植的患者提供了一种替代方案。有些患者由于年龄、合併症以及捐赠心臟的可用性等多种原因不适合进行心臟移植。在这种情况下，心臟辅助装置可以作为长期解决方案，为心臟提供机械支持，使患者能够活得更长久、更健康。这对于老年患者以及那些患有其他疾病而难以符合移植条件的患者来说尤其重要。

除了用于治疗心臟衰竭外，心臟帮浦还有助于预防其他心血管疾病相关的併发症，例如心源性休克和心肌梗塞。透过在这些紧急情况下提供机械循环支持，心臟帮浦可以稳定患者病情，防止心臟进一步受损，从而提高整体存活率并降低长期併发症的风险。

哪些因素正在推动心臟帮浦设备市场的成长？

推动心臟帮浦设备市场快速成长的关键因素包括心臟衰竭衰竭盛行率的上升、心臟帮浦技术的进步、全球人口老化以及对机械循环支援需求的不断增长。其中一个主要驱动因素是全球心臟衰竭患者数量的增加。随着人口老化以及肥胖、高血压和糖尿病等文明病的盛行率上升，心臟衰竭患者的数量正在稳步增长。这显着增加了对心臟帮浦等先进治疗方法的需求，这些疗法能够为那些对药物治疗或微创治疗不再有效的患者提供有效且长期的解决方案。

心臟泵技术的进步是推动市场成长的另一个主要因素。更小巧、更耐用、创伤更小的心臟泵的研发，使得更多患者能够使用心臟泵，包括轻度心臟衰竭患者以及不仿单标示外传统心臟泵的患者。这些技术进步也带来了更好的治疗效果、更少的併发症和更高的存活率，从而推动了心臟帮浦在全球医疗系统中的应用。

全球人口老化也是心臟帮浦设备市场成长的重要推手。随着预期寿命的不断延长，包括心臟衰竭在内的与老龄化相关的心血管疾病的发生率也在上升。老年患者更容易患上削弱心臟功能的疾病，因此他们是心臟泵设备的理想适应症。预计未来几十年老年人口数量将显着增长，因此，作为治疗老龄化心臟衰竭的一种选择，心臟泵的需求预计将会增长。

对机械循环支援装置（包括短期和长期使用）日益增长的需求也推动了市场成长。心臟帮浦装置越来越多地应用于加护治疗环境中，例如高风险心血管手术期间以及心肌梗塞和心源性休克復健期。它们能够稳定患者病情并帮助其康復，使其成为心臟病专家和心臟外科医生的宝贵工具，进一步推动了其在医院和医疗机构的普及。

人们越来越关注如何提高慢性心臟疾病患者的生活品质，这也推动了市场的发展。心臟帮浦装置被视为治疗心臟衰竭的重要选择，因为患者和医疗服务提供者都在寻求能够延长寿命并改善日常功能的解决方案。这些装置能够提高患者的活动能力、缓解症状并全面改善生活质量，这是推动其使用量增加的关键因素。

此外，政府的支持和监管机构对心臟帮浦设备的核准正在扩大这些救命技术的普及范围。美国食品药物管理局(FDA) 和欧洲药品管理局 (EMA) 等监管机构正在越来越多地核准新型心臟泵设备和创新技术，使这些技术能够更广泛地惠及医疗服务提供者和患者。这种监管支持对于推动市场扩张和促进下一代心臟泵技术的研发至关重要。

总之，心臟帮浦设备市场的成长主要受以下因素驱动：心臟衰竭衰竭盛行率上升、技术进步、全球人口老化以及对机械循环支援需求的不断增长。随着医疗系统持续采用心臟泵设备作为治疗进行性心臟疾病的关键解决方案，这些设备将在提高患者生存率、减少再入院率以及改善全球心臟衰竭患者的生活品质方面发挥日益重要的作用。

部分：

依产品（心室辅助装置 (VAD)、主动脉内球囊反搏帮浦 (IABP)、经导管人工心臟 (TAH)）、类型（植入式、体外）及治疗方法（移植过渡治疗 (BTT)、移植合格治疗 (BTC)、根治性治疗 (DT)、其他治疗方法）分类

受访公司范例

  • Abbott Laboratories
  • Abiomed, Inc.
  • Berlin Heart GmbH
  • Fresenius Medical Care AG &Co. KGaA
  • Getinge AB
  • Jarvik Heart, Inc.
  • Medtronic PLC
  • ReliantHeart, Inc.
  • SynCardia Systems, LLC
  • Teleflex Incorporated
  • Terumo Europe NV

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具，革新市场和竞争情报分析。

Market Glass, Inc. 并没有采用典型的 LLM 或产业专用的SLM 方法，而是建立了一个由世界各地领域专家精心策划的内容库，其中包括影片转录、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

在最新发布的报告中，Market Glass, Inc. 将关税对地理市场的影响纳入考量，并根据公司总部所在地、製造地以及进出口（成品和OEM产品）情况，预测企业竞争地位的变化。这种复杂多变的市场现实会从多个方面影响竞争对手，包括增加销货成本、降低盈利和重组供应链，同时也会影响微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲
  • 亚太地区
  • 世界其他地区

第四章 竞赛

简介目录
Product Code: MCP12313

Global Heart Pump Devices Market to Reach US$8.5 Billion by 2030

The global market for Heart Pump Devices estimated at US$3.2 Billion in the year 2024, is expected to reach US$8.5 Billion by 2030, growing at a CAGR of 17.4% over the analysis period 2024-2030. Ventricular Assist Devices (VADs), one of the segments analyzed in the report, is expected to record a 19.1% CAGR and reach US$5.1 Billion by the end of the analysis period. Growth in the Intra-aortic Balloon Pumps (IABPs) segment is estimated at 14.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$884.6 Million While China is Forecast to Grow at 16.4% CAGR

The Heart Pump Devices market in the U.S. is estimated at US$884.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 16.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.7% and 14.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.2% CAGR.

Global Heart Pump Devices Market - Key Trends and Drivers Summarized

Why Are Heart Pump Devices Becoming Essential for Treating Advanced Heart Failure, Supporting Cardiac Surgeries, and Improving Patient Survival Rates?

Heart pump devices have become essential for treating advanced heart failure, supporting cardiac surgeries, and improving patient survival rates. But why are these devices so critical today? With the rising prevalence of heart failure globally, heart pump devices, such as left ventricular assist devices (LVADs) and total artificial hearts (TAHs), are providing life-saving solutions for patients who are no longer responsive to medication or traditional therapies. These devices are crucial in assisting or completely replacing the function of a failing heart by helping it pump blood more effectively, ensuring that vital organs continue to receive sufficient oxygen and nutrients. For many patients with end-stage heart failure, heart pump devices are the only viable option to sustain life while waiting for a heart transplant or as a long-term alternative when transplants are not an option.

In addition to managing heart failure, heart pump devices play a vital role in supporting patients undergoing high-risk cardiac surgeries. In such procedures, temporary mechanical circulatory support provided by heart pump devices ensures that blood flow is maintained, reducing the risk of complications during and after surgery. These devices are also being increasingly used to stabilize patients in critical conditions, such as those recovering from heart attacks or cardiogenic shock, where the heart cannot pump enough blood on its own.

Moreover, heart pump devices significantly improve the quality of life for heart failure patients by reducing symptoms like fatigue, shortness of breath, and fluid retention. By supporting the heart’s function, these devices allow patients to engage in everyday activities with greater ease, improving both physical and mental well-being.

How Are Technological Advancements and Innovations Enhancing the Efficiency, Safety, and Longevity of Heart Pump Devices?

Technological advancements and innovations are significantly enhancing the efficiency, safety, and longevity of heart pump devices, making them more reliable and effective for patients with heart failure. One of the most impactful innovations is the development of smaller, more durable, and less invasive left ventricular assist devices (LVADs). These newer-generation LVADs are designed to be implanted with fewer surgical risks and provide better outcomes for patients. Innovations in miniaturization have allowed these devices to fit into a broader range of patients, including those who previously might not have been candidates due to the size of earlier models. These smaller devices also cause fewer complications, such as infections or blood clots, by minimizing the need for extensive surgical procedures.

Another significant advancement in heart pump technology is the improvement of energy efficiency and battery life. Earlier generations of heart pump devices required external batteries that patients had to carry with them, limiting mobility and convenience. Today, advanced battery technologies allow for longer-lasting, portable power supplies, reducing the need for frequent battery changes or recharging. Some devices are even exploring wireless charging technologies, which would eliminate the need for external power cables and further enhance the patient’s quality of life. These improvements make heart pump devices more practical and less burdensome, allowing patients to move more freely and live more independently.

The integration of artificial intelligence (AI) and data analytics is another key innovation in heart pump devices. AI-powered monitoring systems can continuously track the device's performance and the patient’s physiological parameters, detecting potential issues early and alerting healthcare providers to any signs of malfunction or deterioration. These intelligent systems help optimize device settings and make real-time adjustments to ensure the heart pump is working at peak efficiency. AI algorithms can also predict when a patient may need medical intervention, improving long-term outcomes and reducing the risk of complications.

Biocompatible materials are another area where heart pump devices are seeing significant improvements. New materials used in these devices reduce the risk of blood clotting (thrombosis) and infection, which are common complications associated with heart pumps. The use of advanced coatings and materials that mimic the body’s tissues minimizes the immune system’s response to the device, reducing the need for blood thinners and other medications. This not only enhances patient safety but also extends the longevity of the device by reducing wear and tear.

Remote monitoring capabilities are also transforming the way heart pump devices are managed. Patients with heart pumps can now be monitored remotely through connected health platforms, where healthcare providers can track device performance and patient health metrics in real-time. This allows for early detection of potential issues, reduces the frequency of in-person clinic visits, and provides peace of mind to both patients and clinicians. In addition, advancements in remote monitoring are making it easier for patients to receive personalized care and adjustments to their treatment plans without the need for frequent hospital stays.

Why Are Heart Pump Devices Critical for Reducing Hospital Readmissions, Extending Life Expectancy, and Enhancing Quality of Life for Heart Failure Patients?

Heart pump devices are critical for reducing hospital readmissions, extending life expectancy, and enhancing the quality of life for heart failure patients because they provide a long-term solution for those with severe heart conditions. One of the primary reasons heart pump devices are so valuable is their ability to reduce the frequency of hospital readmissions in patients with chronic heart failure. Heart failure is often characterized by recurring symptoms, leading to repeated hospitalizations as the heart becomes less effective at pumping blood. Heart pump devices alleviate this by consistently supporting the heart’s function, stabilizing the patient’s condition, and reducing the need for frequent medical interventions. This not only improves the patient’s quality of life but also reduces the strain on healthcare systems by lowering the demand for emergency care and hospital resources.

Extending life expectancy is another significant benefit of heart pump devices. For patients with end-stage heart failure, life expectancy is often limited to a few months or years without advanced treatment options. Heart pump devices, particularly LVADs, have been shown to significantly extend survival rates by supporting heart function while patients wait for a heart transplant or as a long-term therapy when transplantation is not feasible. In many cases, patients with LVADs can live for several years with the device, providing them with more time to receive other treatments or maintain a better quality of life.

Enhancing the quality of life for heart failure patients is a key advantage of heart pump devices. Heart failure can severely limit a patient’s ability to perform daily activities, leading to fatigue, shortness of breath, and a reduced ability to participate in physical activities. Heart pump devices help alleviate these symptoms by improving blood flow, allowing patients to regain their strength and energy. This, in turn, enables them to lead more active lives, participate in social activities, and experience a greater sense of independence. Many patients with heart pump devices report significant improvements in their physical and emotional well-being after receiving the device.

Heart pump devices also offer an alternative for patients who are not eligible for heart transplants. For various reasons, including age, comorbidities, or the availability of donor hearts, some patients may not be suitable candidates for heart transplantation. In these cases, heart pump devices serve as a long-term solution, providing mechanical support to the heart and allowing patients to live longer, healthier lives. This is particularly valuable for older patients or those with other medical conditions that complicate their candidacy for a transplant.

In addition to their role in treating heart failure, heart pump devices also help prevent complications related to other cardiovascular conditions, such as cardiogenic shock or heart attacks. By providing mechanical circulatory support during these critical events, heart pump devices can stabilize patients and prevent further damage to the heart, improving overall survival rates and reducing the risk of long-term complications.

What Factors Are Driving the Growth of the Heart Pump Devices Market?

Several key factors are driving the rapid growth of the heart pump devices market, including the increasing prevalence of heart failure, advancements in heart pump technology, the aging global population, and the rising demand for mechanical circulatory support. One of the primary drivers is the growing prevalence of heart failure worldwide. As populations age and lifestyle factors such as obesity, hypertension, and diabetes become more common, the number of individuals suffering from heart failure is steadily increasing. This has created a significant demand for advanced treatment options, such as heart pump devices, that can provide effective, long-term solutions for patients who are no longer responsive to medication or less invasive therapies.

Advancements in heart pump technology are another major factor fueling the growth of the market. The development of smaller, more durable, and less invasive devices has made heart pumps more accessible to a broader range of patients, including those with less severe heart failure or those who may not have been candidates for older-generation devices. These technological improvements have also led to better patient outcomes, fewer complications, and increased survival rates, driving the adoption of heart pump devices in healthcare systems around the world.

The aging global population is also contributing to the growth of the heart pump devices market. As life expectancy continues to rise, the incidence of age-related cardiovascular conditions, including heart failure, is increasing. Older patients are more likely to suffer from conditions that weaken the heart, making them prime candidates for heart pump devices. With the number of elderly individuals projected to grow significantly over the coming decades, the demand for heart pumps as a treatment option for age-related heart failure is expected to rise.

The rising demand for mechanical circulatory support in both short-term and long-term scenarios is another factor driving market growth. Heart pump devices are increasingly being used in critical care settings, such as during high-risk cardiac surgeries or for patients recovering from heart attacks or cardiogenic shock. The ability of heart pump devices to stabilize patients and support recovery has made them a valuable tool for cardiologists and cardiac surgeons, further driving their adoption in hospitals and healthcare facilities.

The growing focus on improving the quality of life for patients with chronic heart conditions is also propelling the market. As patients and healthcare providers seek solutions that not only extend life but also enhance day-to-day functioning, heart pump devices are being viewed as an essential option for managing heart failure. The improvements in patient mobility, reduction in symptoms, and overall better quality of life provided by these devices are significant motivators for their increasing use.

Additionally, government support and regulatory approvals for heart pump devices are expanding access to these life-saving technologies. Regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA), are increasingly approving new heart pump devices and innovations, making these technologies more widely available to healthcare providers and patients. This regulatory support is crucial for driving market expansion and fostering the development of next-generation heart pump technologies.

In conclusion, the growth of the heart pump devices market is driven by the rising prevalence of heart failure, advancements in technology, the aging global population, and the increasing demand for mechanical circulatory support. As healthcare systems continue to adopt heart pump devices as a critical solution for managing advanced heart conditions, these devices will play an increasingly vital role in improving patient survival, reducing hospital readmissions, and enhancing the quality of life for heart failure patients worldwide.

SCOPE OF STUDY:

The report analyzes the Heart Pump Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs), Total Artificial Heart (TAH)); Type (Implantable, Extracorporeal); Therapy (Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT), Other Therapies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 13 Featured) -

  • Abbott Laboratories
  • Abiomed, Inc.
  • Berlin Heart GmbH
  • Fresenius Medical Care AG & Co. KGaA
  • Getinge AB
  • Jarvik Heart, Inc.
  • Medtronic PLC
  • ReliantHeart, Inc.
  • SynCardia Systems, LLC
  • Teleflex Incorporated
  • Terumo Europe NV

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Global Economic Update
    • Heart Pump Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cardiovascular Diseases Propels Demand for Heart Pump Devices
    • Expansion of Heart Transplant Programs Strengthens Business Case for Temporary Heart Pump Devices
    • Increasing Focus on Minimally Invasive Procedures Spurs Adoption of Percutaneous Heart Pumps
    • Growing Aging Population Expands Addressable Market Opportunity for Heart Pump Devices
    • Expansion of Chronic Heart Failure Treatment Programs Bodes Well for Market Growth
    • Future Directions: Development of Fully Implantable Artificial Hearts Accelerates Market Potential
    • Growing Popularity of Bridge-to-Transplant Therapies Expands Adoption of Heart Pumps
    • Expansion of Cardiac Centers and Specialized Clinics Generates Demand for Heart Pump Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Heart Pump Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Heart Pump Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Heart Pump Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Heart Pump Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Ventricular Assist Devices (VADs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Ventricular Assist Devices (VADs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Ventricular Assist Devices (VADs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Intra-aortic Balloon Pumps (IABPs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Intra-aortic Balloon Pumps (IABPs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Intra-aortic Balloon Pumps (IABPs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Total Artificial Heart (TAH) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Total Artificial Heart (TAH) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Total Artificial Heart (TAH) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Implantable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Implantable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Implantable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Extracorporeal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Extracorporeal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Extracorporeal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Bridge-to-Transplant (BTT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Bridge-to-Transplant (BTT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Bridge-to-Transplant (BTT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Bridge-to-Candidacy (BTC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Bridge-to-Candidacy (BTC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Bridge-to-Candidacy (BTC) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Destination Therapy (DT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Destination Therapy (DT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Destination Therapy (DT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other Therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Heart Pump Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Heart Pump Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Heart Pump Devices by Type - Implantable and Extracorporeal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Heart Pump Devices by Type - Implantable and Extracorporeal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Heart Pump Devices by Type - Percentage Breakdown of Value Sales for Implantable and Extracorporeal for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Heart Pump Devices by Therapy - Percentage Breakdown of Value Sales for Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Heart Pump Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Heart Pump Devices by Type - Implantable and Extracorporeal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Heart Pump Devices by Type - Implantable and Extracorporeal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Heart Pump Devices by Type - Percentage Breakdown of Value Sales for Implantable and Extracorporeal for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Heart Pump Devices by Therapy - Percentage Breakdown of Value Sales for Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies for the Years 2015, 2025 & 2030
  • JAPAN
    • Heart Pump Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Heart Pump Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Heart Pump Devices by Type - Implantable and Extracorporeal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Heart Pump Devices by Type - Implantable and Extracorporeal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Heart Pump Devices by Type - Percentage Breakdown of Value Sales for Implantable and Extracorporeal for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Heart Pump Devices by Therapy - Percentage Breakdown of Value Sales for Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies for the Years 2015, 2025 & 2030
  • CHINA
    • Heart Pump Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Heart Pump Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Heart Pump Devices by Type - Implantable and Extracorporeal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Heart Pump Devices by Type - Implantable and Extracorporeal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Heart Pump Devices by Type - Percentage Breakdown of Value Sales for Implantable and Extracorporeal for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Heart Pump Devices by Therapy - Percentage Breakdown of Value Sales for Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies for the Years 2015, 2025 & 2030
  • EUROPE
    • Heart Pump Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Heart Pump Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Heart Pump Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Heart Pump Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Heart Pump Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Heart Pump Devices by Type - Implantable and Extracorporeal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Heart Pump Devices by Type - Implantable and Extracorporeal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Heart Pump Devices by Type - Percentage Breakdown of Value Sales for Implantable and Extracorporeal for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Heart Pump Devices by Therapy - Percentage Breakdown of Value Sales for Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies for the Years 2015, 2025 & 2030
  • FRANCE
    • Heart Pump Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Heart Pump Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Heart Pump Devices by Type - Implantable and Extracorporeal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Heart Pump Devices by Type - Implantable and Extracorporeal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Heart Pump Devices by Type - Percentage Breakdown of Value Sales for Implantable and Extracorporeal for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Heart Pump Devices by Therapy - Percentage Breakdown of Value Sales for Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies for the Years 2015, 2025 & 2030
  • GERMANY
    • Heart Pump Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Heart Pump Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Heart Pump Devices by Type - Implantable and Extracorporeal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Heart Pump Devices by Type - Implantable and Extracorporeal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Heart Pump Devices by Type - Percentage Breakdown of Value Sales for Implantable and Extracorporeal for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Heart Pump Devices by Therapy - Percentage Breakdown of Value Sales for Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Heart Pump Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Heart Pump Devices by Type - Implantable and Extracorporeal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Heart Pump Devices by Type - Implantable and Extracorporeal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Heart Pump Devices by Type - Percentage Breakdown of Value Sales for Implantable and Extracorporeal for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Heart Pump Devices by Therapy - Percentage Breakdown of Value Sales for Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Heart Pump Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Heart Pump Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Heart Pump Devices by Type - Implantable and Extracorporeal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Heart Pump Devices by Type - Implantable and Extracorporeal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Heart Pump Devices by Type - Percentage Breakdown of Value Sales for Implantable and Extracorporeal for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Heart Pump Devices by Therapy - Percentage Breakdown of Value Sales for Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Rest of Europe 15-Year Perspective for Heart Pump Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) for the Years 2015, 2025 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Heart Pump Devices by Type - Implantable and Extracorporeal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Heart Pump Devices by Type - Implantable and Extracorporeal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for Heart Pump Devices by Type - Percentage Breakdown of Value Sales for Implantable and Extracorporeal for the Years 2015, 2025 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Heart Pump Devices by Therapy - Percentage Breakdown of Value Sales for Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Heart Pump Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Asia-Pacific 15-Year Perspective for Heart Pump Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) for the Years 2015, 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Heart Pump Devices by Type - Implantable and Extracorporeal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Heart Pump Devices by Type - Implantable and Extracorporeal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for Heart Pump Devices by Type - Percentage Breakdown of Value Sales for Implantable and Extracorporeal for the Years 2015, 2025 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Heart Pump Devices by Therapy - Percentage Breakdown of Value Sales for Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of World 15-Year Perspective for Heart Pump Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Heart Pump Devices by Type - Implantable and Extracorporeal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Heart Pump Devices by Type - Implantable and Extracorporeal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of World 15-Year Perspective for Heart Pump Devices by Type - Percentage Breakdown of Value Sales for Implantable and Extracorporeal for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Heart Pump Devices by Therapy - Percentage Breakdown of Value Sales for Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies for the Years 2015, 2025 & 2030

IV. COMPETITION